DEA & Big Pharma Working To Control Growing Marijuana Market

The agency announced Thursday that drugs including “finished dosage formulations” of CBD with THC below 0.1% will be considered Schedule 5 drugs, as long as the medications have been approved by the U.S. Food and Drug Administration.

See Also: (David Knight) – Exposed: Amazon Shadowbans Pro-Liberty Book

David Knight interviews David Thomas Roberts who is a Texas-based publisher, and says it has been in conversations with the state attorney general about an investigation into Amazon’s political bias after the online giant suppressed the sales of a conservative/libertarian-themed book.